Thank you for tuning in to our webinar, Planning for Accelerated Approval: Timing is Everything.
Accelerated approval remains an important pathway for therapies addressing serious conditions and unmet medical needs. But evolving FDA expectations mean sponsors must plan earlier and take a coordinated approach across clinical development, regulatory strategy, operations, confirmatory trials, and CMC.
Success requires cross-functional alignment and a development strategy that anticipates potential challenges before they become roadblocks.
Our experts will guide you toward success. We can help you:
- Navigate recent changes to the accelerated approval pathway
- Align clinical and regulatory strategy early
- Design confirmatory trials ahead of submission
- Strengthen operational and inspection readiness
- Integrate CMC considerations into development planning
Meet Our Experts:
Seth DePuy, Ph.D.Sr. Director, Regulatory & Product Strategy |
Paulla DennisExecutive Director, Program Strategy, Rare Disease, Pediatrics, Cell and Gene Therapy |
Ready to get started?
Complete the form to have your questions answered by our experts.